Women’s Health Bulletin

Published by: Kowsar
Crossmark

Assessment of Kidney Function and 24-Hour Urine of the Patients with Renal Stone; Women Have Lower Urine Volume and Higher Urine Citrate

Maryam Pakfetrat 1 , Leila Malekmakan ORCID 1 , * , Taraneh Tadayon 1 , Amin Nikfar 1 and Afshin Mansourian 2
Authors Information
1 Shiraz Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
2 Department of Anesthesiology, Yasuj University of Medical Sciences, Yasuj, Iran
Article information
  • Women’s Health Bulletin: January 1, 2019, 6 (1); e88048
  • Published Online: February 20, 2019
  • Article Type: Research Article
  • Received: December 22, 2018
  • Revised: February 6, 2019
  • Accepted: February 14, 2019
  • DOI: 10.5812/whb.88048

How to Cite: Pakfetrat M, Malekmakan L, Tadayon T, Nikfar A , Mansourian A. Assessment of Kidney Function and 24-Hour Urine of the Patients with Renal Stone; Women Have Lower Urine Volume and Higher Urine Citrate, Women Health Bull. 2019 ; 6(1):e88048. doi: 10.5812/whb.88048.

Abstract
Copyright © 2019, Women’s Health Bulletin. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Litwin MS, Saigal CS, Yano EM, Avila C, Geschwind SA, Hanley JM, et al. Urologic diseases in America project: Analytical methods and principal findings. J Urol. 2005;173(3):933-7. doi: 10.1097/01.ju.0000152365.43125.3b. [PubMed: 15711342].
  • 2. Knoll T. Epidemiology, pathogenesis, and pathophysiology of urolithiasis. Eur Urol Suppl. 2010;9(12):802-6. doi: 10.1016/j.eursup.2010.11.006.
  • 3. Bartoletti R, Cai T, Mondaini N, Melone F, Travaglini F, Carini M, et al. Epidemiology and risk factors in urolithiasis. Urol Int. 2007;79 Suppl 1:3-7. doi: 10.1159/000104434. [PubMed: 17726345].
  • 4. Raheem OA, Khandwala YS, Sur RL, Ghani KR, Denstedt JD. Burden of urolithiasis: Trends in prevalence, treatments, and costs. Eur Urol Focus. 2017;3(1):18-26. doi: 10.1016/j.euf.2017.04.001. [PubMed: 28720363].
  • 5. Safarinejad MR. Adult urolithiasis in a population-based study in Iran: Prevalence, incidence, and associated risk factors. Urol Res. 2007;35(2):73-82. doi: 10.1007/s00240-007-0084-6. [PubMed: 17361397].
  • 6. Bensalah K, Tuncel A, Gupta A, Raman JD, Pearle MS, Lotan Y. Determinants of quality of life for patients with kidney stones. J Urol. 2008;179(6):2238-43. discussion 2243. doi: 10.1016/j.juro.2008.01.116. [PubMed: 18423704].
  • 7. Malekmakan L, Haghpanah S, Pakfetrat M, Malekmakan A, Khajehdehi P. Causes of chronic renal failure among Iranian hemodialysis patients. Saudi J Kidney Dis Transpl. 2009;20(3):501-4. [PubMed: 19414964].
  • 8. Bagga HS, Chi T, Miller J, Stoller ML. New insights into the pathogenesis of renal calculi. Urol Clin North Am. 2013;40(1):1-12. doi: 10.1016/j.ucl.2012.09.006. [PubMed: 23177630]. [PubMed Central: PMC4165395].
  • 9. Ramaswamy K, Shah O. Metabolic syndrome and nephrolithiasis. Transl Androl Urol. 2014;3(3):285-95. doi: 10.3978/j.issn.2223-4683.2014.06.03. [PubMed: 26816779]. [PubMed Central: PMC4708567].
  • 10. Kasper DL, Harrison TR. Harrison's principles of internal medicine. New york: Mcgraw-Hill Medical; 2012.
  • 11. Spivacow FR, Negri AL, del Valle EE, Calvino I, Zanchetta JR. Clinical and metabolic risk factor evaluation in young adults with kidney stones. Int Urol Nephrol. 2010;42(2):471-5. doi: 10.1007/s11255-009-9623-0. [PubMed: 19653114].
  • 12. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. Kidney Int. 2001;59(6):2290-8. doi: 10.1046/j.1523-1755.2001.00746.x. [PubMed: 11380833].
  • 13. Perrier ET, Buendia-Jimenez I, Vecchio M, Armstrong LE, Tack I, Klein A. Twenty-four-hour urine osmolality as a physiological index of adequate water intake. Dis Markers. 2015;2015:231063. doi: 10.1155/2015/231063. [PubMed: 25866433]. [PubMed Central: PMC4381985].
  • 14. Moe OW. Kidney stones: Pathophysiology and medical management. Lancet. 2006;367(9507):333-44. doi: 10.1016/S0140-6736(06)68071-9. [PubMed: 16443041].
  • 15. Hosseini MM, Eshraghian A, Dehghanian I, Irani D, Amini M. Metabolic abnormalities in patients with nephrolithiasis: Comparison of first-episode with recurrent cases in Southern Iran. Int Urol Nephrol. 2010;42(1):127-31. doi: 10.1007/s11255-009-9599-9. [PubMed: 19548107].
  • 16. Nouri-Majalan N, Baghianimoghadam B, Amiri N, Moghaddasi-Moosavi S. Metabolic abnormalities in patients with recurrent stone formation in a hot territory. Bratisl Lek Listy. 2010;111(2):79-82. [PubMed: 20429319].
  • 17. Gault MH, Chafe L. Relationship of frequency, age, sex, stone weight and composition in 15,624 stones: Comparison of resutls for 1980 to 1983 and 1995 to 1998. J Urol. 2000;164(2):302-7. doi: 10.1016/S0022-5347(05)67345-4. [PubMed: 10893570].
  • 18. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. Family history and risk of kidney stones. J Am Soc Nephrol. 1997;8(10):1568-73. [PubMed: 9335385].
  • 19. Ljunghall S, Danielson BG, Fellstrom B, Holmgren K, Johansson G, Wikstrom B. Family history of renal stones in recurrent stone patients. Br J Urol. 1985;57(4):370-4. doi: 10.1111/j.1464-410X.1985.tb06290.x. [PubMed: 4027504].
  • 20. Pearle MS, Calhoun EA, Curhan GC, Urologic Diseases of America P. Urologic diseases in America project: Urolithiasis. J Urol. 2005;173(3):848-57. doi: 10.1097/01.ju.0000152082.14384.d7. [PubMed: 15711292].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments